(Yicai Global) Aug. 27 -- German pharmaceutical giant Bayer will invest more than EUR50 million (USD59.1 million) to increase its largest drug packaging site's capacity by 40 percent to guarantee a stable supply of prescription drugs in China.

The project, which is expected to be ready by the end of 2022, should strengthen the plant's position as one of Bayer's most advanced production bases in the world, the Leverkusen-headquartered firm said in a statement on its website yesterday.

Built in 1995, the factory makes products to treat diabetes, cardiovascular and cerebrovascular diseases, and chronic illnesses. In 2016, the parent started upgrading the plant to become its largest packaging base for prescription drugs, intending to spend EUR100 million.

Editor: Emmi Laine